Avanos Medical, Inc. (AVNS)
Automate Your Wheel Strategy on AVNS
With Tiblio's Option Bot, you can configure your own wheel strategy including AVNS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol AVNS
- Rev/Share 14.9501
- Book/Share 18.2082
- PB 0.6903
- Debt/Equity 0.1679
- CurrentRatio 2.5685
- ROIC -0.3693
- MktCap 581287080.0
- FreeCF/Share 2.4729
- PFCF 5.099
- PE -1.5067
- Debt/Assets 0.1272
- DivYield 0
- ROE -0.3734
- Rating B-
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 4
- P/B Score 4
- D/E Score 3
Recent Analyst Ratings
Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
---|---|---|---|---|---|---|---|
No ratings available. |
News
Avanos Medical (AVNS) International Revenue in Focus: Trends and Expectations
Published: May 13, 2025 by: Zacks Investment Research
Sentiment: Neutral
Explore Avanos Medical's (AVNS) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Read More
New Strong Sell Stocks for May 9th
Published: May 09, 2025 by: Zacks Investment Research
Sentiment: Negative
AVNS, BCC and AMPY have been added to the Zacks Rank #5 (Strong Sell) List on May 9, 2025.
Read More
AVNS Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Strength in Avanos' SNS segment drives its first-quarter 2025 performance despite global macroeconomic challenges.
Read More
Avanos Medical, Inc. (AVNS) Q1 2025 Earnings Call Transcript
Published: May 06, 2025 by: Seeking Alpha
Sentiment: Neutral
Avanos Medical, Inc. (NYSE:AVNS ) Q1 2025 Earnings Conference Call May 6, 2025 9:00 AM ET Company Participants Scott Galovan - Vice President of Strategy and Corporate Development Dave Pacitti - Chief Executive Officer Jason Pickett - Interim Chief Financial Officer and Treasurer Conference Call Participants Rick Wise - Stifel Daniel Stauder - Citizens JMP Operator Good morning, ladies and gentlemen, and welcome to the Avanos Medical, Avanos First Quarter 2025 Earnings Call. [Operator Instructions] This call is being recorded on Tuesday, May 6, 2025.
Read More
Avanos Medical (AVNS) Q1 Earnings and Revenues Top Estimates
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Avanos Medical (AVNS) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.22 per share a year ago.
Read More
Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2025 Financial Results
Published: April 28, 2025 by: PRNewsWire
Sentiment: Neutral
ALPHARETTA, Ga. , April 28, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2025 on Tuesday, May 6 at 9 a.m.
Read More
AVNS Stock Gains Following Direct Sales Deal for MIC-KEY in the UK
Published: April 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Avanos takes direct control of MIC-KEY sales in the UK, enhancing market presence, customer engagement and service efficiency, starting July 2025.
Read More
New Strong Sell Stocks for March 24th
Published: March 24, 2025 by: Zacks Investment Research
Sentiment: Negative
AVNS, AIRS and AMPH have been added to the Zacks Rank #5 (Strong Sell) List on March 24, 2025.
Read More
New Strong Sell Stocks for March 18th
Published: March 18, 2025 by: Zacks Investment Research
Sentiment: Negative
AVNS, CARS and CABO have been added to the Zacks Rank #5 (Strong Sell) List on March 18, 2025.
Read More
AVNS Stock Gains Post Q4 Earnings & Revenue Beat, Margins Contract
Published: February 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Strength in Avanos' Digestive Health segment drives its fourth-quarter 2024 performance despite global macroeconomic challenges.
Read More
Avanos Medical Inc. (AVNS) Q4 2024 Earnings Call Transcript
Published: February 26, 2025 by: Seeking Alpha
Sentiment: Neutral
Avanos Medical Inc. (NYSE:AVNS ) Q4 2024 Earnings Conference Call February 26, 2025 9:00 AM ET Company Participants Scott Galovan - Vice President of Strategy & Corporate Development Michael Greiner - Interim Chief Executive Officer Conference Call Participants Danny Stauder - Citizens GMP Operator Good morning ladies and gentlemen. Welcome to the Avanos Fourth Quarter 2024 Earnings Call.
Read More
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2024 Results
Published: February 26, 2025 by: PRNewsWire
Sentiment: Neutral
ALPHARETTA, Ga. , Feb. 26, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2024 results.
Read More
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2024 Financial Results
Published: February 19, 2025 by: PRNewsWire
Sentiment: Neutral
ALPHARETTA, Ga. , Feb. 19, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2024 on Wednesday, Feb. 26 at 9 a.m.
Read More
About Avanos Medical, Inc. (AVNS)
- IPO Date 2014-10-21
- Website https://avanos.com
- Industry Medical - Devices
- CEO Mr. Sigfrido Delgado
- Employees 2227